This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

Continue
Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
New eMC coming June 2013...

BPL (Bio Products Laboratory)
Dagger Lane, Elstree, Hertfordshire, WD6 3BX
Telephone: +44 (0)20 8957 2200
Fax: +44 (0)20 8957 2601
WWW: http://www.bpl.co.uk
Medical Information Direct Line: +44 (0)20 8957 2622
Medical Information e-mail: medinfo@bpl.co.uk
Customer Care direct line: +44 (0)20 8957 2342
Medical Information Fax: +44 (0)20 8957 2611

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 29/01/2013
PIL Human Hepatitis B Immunoglobulin

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/01/2013 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision
  • Company name change or merger
Updated on 18/07/2012 and displayed until 29/01/2013
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 07/01/2009 and displayed until 18/07/2012
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Correction of spelling/typing errors
  • Change due to user-testing of patient information
Updated on 21/09/2007 and displayed until 07/01/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 07/07/2004 and displayed until 21/09/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics